One method, three safety questions
Small molecules, nanomaterials, environmental chemicals — different test articles, yet the decision output sits on one comparable table.
Cardiovascular toxicity assessment and
risk stratification of 500 small molecules
With a large candidate library, the goal is not to explain each compound individually but to surface and rank risk signals within a limited time.
High risk: clear cardiovascular toxicity signals; intermediate: potential risk requiring attention; low: no clear risk signal, comparatively good safety.
Cardiovascular safety assessment of
black phosphorus materials and nano drug-delivery systems
Nanomaterial risk rarely lies in "toxic or not" but in the combination of dose, exposure route and local structural injury. It has to be observed at the level of the whole circulation.
Readouts illustrate the dashboard format; values vary with sample, dose and batch and do not represent fixed conclusions.
Vascular toxicity profile of
150 chemicals of environmental health concern
When sample numbers and structural diversity are high, the value lies not in single conclusions but in clusterable injury patterns and a rankable risk list.
Clustering and ranking compress many samples into an actionable list; grouping thresholds follow the criteria set for the project.
About the case data Compound counts, stratum proportions and readouts come from platform demonstration material and illustrate deliverable format and analytical dimensions; they do not constitute toxicity conclusions for any specific compound or material. Actual projects report under the agreed protocol.
Which design fits your samples?
Tell us the sample type, number and target endpoints, and we will propose the dose design and deliverable list.